Nevro Corp reports results for the quarter ended December 31 - Earnings Summary

Nevro

05/03/2025 03:00

Nevro Corp NVRO.N reported a quarterly adjusted loss of 40 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -25 cents.  The mean expectation of fourteen analysts for the quarter was for a loss of 77 cents per share. Wall Street expected results to range from -95 cents to -65 cents per share.

Revenue fell 9.1% to $105.55 million from a year ago; analysts expected $102.54 million.

Nevro Corp's reported EPS for the quarter was a loss of $1.41​.

The company reported a quarterly loss of $53.11 million.

Nevro Corp shares had risen by 53.8% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 1.4% in the last three months.​

In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 13 "hold" and 1 "sell" or "strong sell."

The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Nevro Corp is $5.85

This summary was machine generated from LSEG data March 5 at 03:00 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Dec. 31 2024
-0.77
-0.40
Beat
Sep. 30 2024
-0.81
-0.41
Beat
Jun. 30 2024
-0.68
-0.53
Beat
Mar. 31 2024
-1.05
-0.58
Beat